Episode 202: The MS Prodrome with Dr. Helen Tremlett
RealTalk MS16 Heinä 2021

Episode 202: The MS Prodrome with Dr. Helen Tremlett

In medicine, a prodrome is a set of signs or symptoms that can appear years before the major symptoms of an illness develop. Recognizing the prodromal phase of MS could mean that, one day, someone who is highly likely to be diagnosed with multiple sclerosis could receive proactive treatment years in advance and, perhaps, never develop any MS symptoms.

Dr. Helen Tremlett, a professor, and the Canada Research Chair in Neuroepidemiology and Multiple Sclerosis at the University of British Columbia, is joining me this week to discuss how understanding the MS prodrome can fundamentally change the way that MS is diagnosed and treated.

We'll also tell you about a study that shows early treatment with high-efficacy disease-modifying therapies can significantly reduce relapse rates for people living with active secondary progressive MS.

We'll share results from a study that shows, on their first visit to a neurologist, Black people have more severe MS than White people.

We'll tell you about two Phase 3 clinical trials that have just received approval from the U.S. Food & Drug Administration.

We'll share the results of a Belgian study that analyzed the efficacy of a cannabis spray in treating MS spasticity and improving quality of life.

And we'll give you a heads-up about a new web series that features raw, unfiltered conversations about the good, bad, and messy parts of living with MS.

We have a lot to talk about! Are you ready for RealTalk MS??!

What is the MS prodrome? :22

Does early treatment with high-efficacy DMTs reduce relapse rates in people with secondary progressive MS? 2:32

Study shows Blacks with MS present with more severe disease and greater disability than Whites 5:54

FDA approves 2 Phase 3 clinical trials for a potential disease-modifying therapy 8:18

Study shows cannabis spray improves spasticity and quality of life for people living with MS 10:15

MS Confidential is the web series you don't want to miss 11:47

Dr. Helen Tremlett explains what the MS prodrome is and why it's important 14:40

Share this episode 28:20

Download the free RealTalk MS app 28:48

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/202

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society COVID-19 Vaccine Guidance for People Living with MS
https://www.nationalmssociety.org/coronavirus-covid-19-information/multiple-sclerosis-and-coronavirus/covid-19-vaccine-guidance

STUDY: Effects of High and Low Efficacy Therapy in Secondary Progressive Multiple Sclerosis
https://n.neurology.org/content/early/2021/06/30/WNL.0000000000012354

STUDY: Association of Disease Severity and Socioeconomic Status in Black and White Americans with Multiple Sclerosis
https://n.neurology.org/content/early/2021/06/30/WNL.0000000000012362

STUDY: Sativex Cannabinoid Oromucosal Spray in Patients with Resistant Multiple Sclerosis Spasticity: The Belgian Experience
https://pubmed.ncbi.nlm.nih.gov/34157999/

Episode 1 of MS Confidential: Vanity
https://www.youtube.com/watch?v=thtC81q7LVA

Where to find future episodes of MS Confidential
https://unfixedmedia.com/ms-confidential

Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

Download the RealTalk MS App for iOS
https://itunes.apple.com/us/app/realtalk-ms/id1436917200

Download the RealTalk MS App for Android
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk

Give RealTalk MS a rating and review
http://www.realtalkms.com/review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 202
Guest: Dr. Helen Tremlett

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS

Privacy Policy

Jaksot(505)

Episode 443: The 2026 ACTRIMS Forum (Part 3) with Dr. Helen Tremlett, Dr. Ilana Katz Sand, and Kathy Smith

Episode 443: The 2026 ACTRIMS Forum (Part 3) with Dr. Helen Tremlett, Dr. Ilana Katz Sand, and Kathy Smith

Welcome back to the third and final part of our coverage of the 2026 ACTRIMS Forum. This week's episode bridges the gap between groundbreaking clinical research and the nuanced reality of living with ...

23 Helmi 35min

Episode 442: The 2026 ACTRIMS Forum (Part 2) with Dr. Jeffrey Cohen, Dr. Daniel Ontaneda, and Kristine Werner Ozug

Episode 442: The 2026 ACTRIMS Forum (Part 2) with Dr. Jeffrey Cohen, Dr. Daniel Ontaneda, and Kristine Werner Ozug

Welcome back to Part Two of our coverage of the 2026 ACTRIMS Forum. This week, we shift our focus to emerging therapies and clinical insights that are re-shaping the future of MS care. From the latest...

16 Helmi 44min

Episode 441: The 2026 ACTRIMS Forum with Dr. Manuel Friese, Dr. Amit Bar-Or, and Dr. Haritha Desu

Episode 441: The 2026 ACTRIMS Forum with Dr. Manuel Friese, Dr. Amit Bar-Or, and Dr. Haritha Desu

Last week, over 1,400 scientists and clinicians gathered in San Diego, California, at the 2026 Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting, better known as the A...

9 Helmi 33min

Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte

Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte

This past December, the FDA issued a Complete Response Letter to drug manufacturer Sanofi in response to Sanofi's application seeking approval for Tolebrutinib, the first in a new category of investig...

2 Helmi 39min

Episode 439: Preventing MS with Dr. Bruce Bebo

Episode 439: Preventing MS with Dr. Bruce Bebo

The first coordinated global research strategy to prevent MS has been announced. This week, Dr. Bruce Bebo, the National MS Society's Executive Vice President and Chief Research & Medical Affairs Offi...

26 Tammi 32min

Episode 438: The Discovery of 2 MS Subtypes with Dr. Arman Eshaghi

Episode 438: The Discovery of 2 MS Subtypes with Dr. Arman Eshaghi

One of the more confusing aspects of MS is that it can present differently from one person to the next. A research team at University College London may have uncovered a reason for that when they iden...

19 Tammi 29min

Episode 437: Remembering David Mitchell

Episode 437: Remembering David Mitchell

I don't have to remind anyone who listens to this podcast that the cost of MS disease-modifying therapies is obscenely high. And we're not just talking about relatively new medications. Older medicati...

12 Tammi 29min

Episode 436: 3 Questions Your Neurologist Should Be Asking Themselves with Dr. Leorah Freeman

Episode 436: 3 Questions Your Neurologist Should Be Asking Themselves with Dr. Leorah Freeman

Scientists are expanding our understanding of MS at an unprecedented pace. This week, Dr. Leorah Freeman discusses why, as new discoveries and medications enter clinical practice, neurologists and MS ...

5 Tammi 34min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
vakeva-elama-viisaampi-mieli-vahvempi-keho
tiedenaiset-podcast
katilon-kahvitunti
puhu-muru
rss-pt-paahtio
meditaatiot-suomeksi
rss-kuumilla-aalloilla
rss-pitaisko-erota
audio-sport-juoksu
junnut-pelissa
fitnessvastaanotto
terapiassa
rss-nautinto
paritellen
kehorauhaa
rss-mighty-finland-podcast
rss-kyykkya-ja-kuoharia